Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary Tract Infections in Patients With Neurogenic Bladder

NCT06588010 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Neurogenic Bladder

Interventions

DRUG: OM-89 [Uro-Vaxom® Capsule]
DRUG: OM-89 [Uro-Vaxom® Capsule] OM-89 placebo [Uro-Vaxom® Capsule placebo]

Sponsor

Centre Hospitalier Universitaire Dijon